Tag: generic drugs
GENERAL Glenmark Gets US FDA Approval For Fluticasone Propionate Nasal Spray

Glenmark Pharmaceuticals Ltd has received approval from the US Food and Drug Administration (US FDA) for Fluticasone Propionate Nasal Spray USP, 0.05 mg (50 mcg)/spray, strengthening its respiratory portfolio in the US market. The company said its Fluticasone Propionate Nasal Spray is bioequivalent and therapeutically equivalent to Flonase Nasal Spray, 0.05 mg/spray, the reference listed […]

CW Bureau · Aug 20, 2026
GENERAL Sun Pharma Receives Big Legal Boost As US Court Upholds Lipitor Ruling

Sun Pharmaceutical Industries Ltd has secured a significant legal victory in long-running antitrust litigation in the US related to its 2008 patent litigation settlement with Pfizer concerning generic Lipitor (Atorvastatin). The United States Court of Appeals for the Third Circuit has affirmed the order of the US District Court granting summary judgment in its entirety […]

CW Bureau · Aug 17, 2026
GENERAL Kwality Pharma Ups FY27 Guidance, Targets ₹1,000 Cr Revenue By FY29

Kwality Pharmaceutical Ltd, which has doubled its turnover to ₹500 crore in three years, has raised its FY27 revenue guidance to over ₹700 crore from ₹650 crore and is targeting more than ₹1,000 crore by FY29. “Over the longer term, we continue to work toward doubling revenue over the next three years, with a goal […]

CW Bureau · Aug 10, 2026
GENERAL Glenmark Scales Up US Injectables Presence With Generic Sugammadex

Glenmark Pharmaceuticals Inc., USA, has launched Sugammadex Injection in the United States, expanding its injectables portfolio with a generic version of Merck Sharp & Dohme LLC’s blockbuster anaesthesia reversal drug BRIDION. The company said the product is available in 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) single-dose vials. Glenmark’s Sugammadex Injection […]

CW Bureau · Jul 29, 2026
GENERAL Aurobindo Pharma USA Gets USFTC Nod For $250-Mn Lannett acquisition

Aurobindo Pharma USA, Inc, a wholly owned subsidiary of Aurobindo Pharma Ltd, has received approval from the US Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC. The transaction, valued at $250 million on a cash-free, debt-free basis and inclusive of normalised working capital, is expected to close before the end […]

CW Bureau · Jun 22, 2026
GENERAL Indian Pharma Firms To Gain Up To $5 Bn From Global Patent Cliff: CareEdge

Indian pharmaceutical companies are poised to benefit from a major global patent expiry cycle, with drugs generating nearly $142 billion in sales in CY25 set to lose exclusivity between 2026 and 2030, according to a report by CareEdge Ratings. The report estimates that the upcoming patent cliff could create a market opportunity of over $30-40 […]

CW Bureau · Jun 19, 2026
GENERAL Aurobindo Pharma Gets USFDA Nod For Dapagliflozin-Metformin Combo

Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Dapagliflozin and Metformin Hydrochloride extended-release tablets in multiple strengths such as 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg. The approved formulation is bioequivalent and therapeutically equivalent to the reference listed […]

CW Bureau · Apr 7, 2026